Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism

Thrombosis Journal

Table 1 Food and Drug Administration-approved indications of parenteral anticoagulants available for the treatment and prevention of venous thromboembolism in the US

Indication	Enoxaparin	Dalteparin	Tinzaparin	Fondaparinux
Prophylaxis
Hip replacement surgery	Yes	Yes	No	Yes
Knee replacement surgery	Yes	No	No	Yes
Hip fracture surgery	No	No	No	Yes
Abdominal surgery	Yes	Yes	No	Yes
Acutely ill medical patients	Yes	Yes	No	No
Treatment	Yes	No	Yes	Yes
	- Inpatient DVT with/without PE - Outpatient DVT without PE		- Inpatient DVT with/without PE	- DVT - PE when initial therapy is administered in the hospital
Secondary prophylaxis/extended treatment in cancer patients	No	Yes	No	No

ISSN: 1477-9560